logo

CALL TO SCHEDULE A
FREE CONSULTATION

205-995-2412
YOU PAY NO FEE UNTIL WE WIN

Alabama Invokana Lawyer


Approved in March 2013, Invokana (canagliflozin) is an SGLT2 Inhibitor used to treat adults with Type 2 diabetes, manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. SGLT2 inhibitors work by preventing high blood sugar by helping the patient's kidneys remove excess sugar through their urine. In May 2015, the U.S.

Food and Drug Administration (FDA) issued a warning the drug has been lined to cases of ketoacidosis, a serious condition where there is too much acid in the blood. Complications of diabetic ketoacidosis include difficulty breathing, nausea/vomiting, abdominal pain, confusion and unusual fatigue or sleepiness. The condition can lead to diabetic coma and/or death.

Contact Us

Call 205-995-2412   Never Settle For Less

Top Case Results

$15,100,000.00*

Automobile Accident Verdict


$11,000,000.00*

Automobile Accident Settlement


$2,000,000.00*

Automobile Accident Settlement


$1,650,000.00*

Premises Liability